Omalizumab reduces asthma exacerbations among responders at 28 weeks: the INNOVATE study

被引：0
|
作者：
Bousquet, J. [1 ]
Humbert, M. [2 ]
Rao, S. [3 ]
Pethe, A. [4 ]
Manga, V [3 ]
机构：
[1] Hop Arnaud de Villeneuve, Serv Pneumol, Montpellier, France
[2] Univ Paris 11, Hop Bicetre, Paris, France
[3] Novartis Pharma AG, Basel, Switzerland
[4] Novartis Healthcare, Hyderabad, Andhra Pradesh, India
来源：
ALLERGY | 2014年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1445
引用
收藏
页码：519 / 519
页数：1
相关论文
共 50 条
  • [31] Lansoprazole for 24 weeks reduces asthma exacerbations and improves quality of life in subjects with symptoms of acid reflux - A multicenter, randomized, double-blind, placebo controlled trial
    Littner, MR
    Leung, FW
    Ballard, ED
    Huang, BD
    Samra, NK
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S13 - S13
  • [32] RISK OF SERIOUS ASTHMA EXACERBATIONS ASSOCIATED WITH LONG-ACTING-BETA-AGONISTS AMONG MEDICAID PATIENTS WITH ASTHMA: A RETROSPECTIVE COHORT STUDY
    Guo, J. J.
    Tsai, K.
    Kelton, C. M.
    Bian, B.
    Wigle, P.
    VALUE IN HEALTH, 2010, 13 (07) : A560 - A560
  • [33] Risk of Serious Asthma Exacerbations Associated with Long-Acting-Beta-Agonists among Medicaid Patients with Asthma: A Retrospective Cohort Study
    Guo, Jeff J.
    Tsai, Katherine
    Kelton, Christine M. L.
    Bian, Boyang
    Wigle, Patricia R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S64 - S64
  • [34] Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: Results from the Phase 3 NAVIGATOR Study
    Hoyte, Flavia
    Martin, Neil
    Kmita, Kamil
    Roseti, Stephanie
    Llanos-Ackert, Jean-Pierre
    Lindsley, Andrew
    Colice, Gene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB63 - AB63
  • [35] DUPILUMAB IMPROVES ASTHMA CONTROL AND REDUCES FRACTIONAL EXHALED NITRIC OXIDE AND EXACERBATIONS WITH INHALED CORTICOSTEROID WITHDRAWAL: A PHASE 2 STUDY
    Wechsler, Michael E.
    Jackson, David
    Rabe, Klaus F.
    Pavord, Ian D.
    Virchow, J. C.
    Katial, Rohit
    Israel, Elliot
    Xia, Changming
    Soliman, Mena
    Pandit-Abid, Nami
    Jacob-Nara, Juby A.
    Sacks, Harry
    Rowe, Paul J.
    Deniz, Yamo
    CHEST, 2024, 166 (04) : 4779A - 4796A
  • [36] A PROSPECTIVE STUDY INVESTIGATING EXACERBATIONS, HEALTHCARE UTILISATION AND HEALTH ECONOMIC INDICATORS IN OMALIZUMAB TREATED SEVERE ALLERGIC ASTHMA PATIENTS RESULTS FROM AN INTERIM ANALYSIS OF THE APEX II STUDY
    Masoli, M.
    Menzies-Gow, A.
    Dobson, L.
    Morjaria, J. B.
    Allcock, R.
    Niven, R.
    THORAX, 2014, 69 : A50 - A51
  • [37] DUPILUMAB REDUCES SEVERE OUTPATIENT ASTHMA EXACERBATIONS, CUMULATIVE DOSE, AND TOTAL NUMBER OF DAYS OF SYSTEMIC CORTICOSTEROID USE AMONG PATIENTS WITH MODERATE-TO-SEVERE TYPE-2 ASTHMA
    Canonica, Giorgio Walter
    Zeiger, Robert
    Castro, Mario
    Msihid, Jerome
    Ortiz, Benjamin
    Pandit-Abid, Nami
    Kamat, Siddhesh
    Khan, Asif
    CHEST, 2020, 158 (04) : 1810A - 1812A
  • [38] Dupilumab Reduces Severe Exacerbations and Improves Lung Function in Late-Onset, Uncontrolled, Moderate-to-Severe Asthma Patients Enrolled in the LIBERTY ASTHMA QUEST Study
    Hanania, N. A.
    Bateman, E. D.
    Castro, M.
    Pavord, I. D.
    Papi, A.
    FitzGerald, J. M.
    Maspero, J. F.
    Katelaris, C.
    Singh, D.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Amin, N.
    Staudinger, H. W.
    Graham, N. M. H.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [39] The incidence of malignancy is similar among asthma patients treated with or without omalizumab: results from the long-term EXCELS study
    Long, A. A.
    Rahmaoui, A.
    Rothman, K. J.
    Guinan, E. C.
    Eisner, M. D.
    Bradley, M. S.
    Iribarren, C.
    Chen, H.
    Carrigan, G.
    Rosen, K.
    Szefler, S. J.
    ALLERGY, 2013, 68 : 39 - 39
  • [40] Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma
    Iribarren, Carlos
    Rahmaoui, Abdelkader
    Long, Aidan A.
    Szefler, Stanley J.
    Bradley, Mary S.
    Carrigan, Gillis
    Eisner, Mark D.
    Chen, Hubert
    Omachi, Theodore A.
    Farkouh, Michael E.
    Rothman, Kenneth J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (05) : 1489 - +
12345